• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Cordis hires Cypher investigator as medical affairs VP

Cordis hires Cypher investigator as medical affairs VP

March 30, 2010 By MassDevice staff

Cordis logo

Cordis Corp. tapped the lead investigator in clinical trials of its Cypher drug-eluting stent, Dr. Christian Spaulding, to be its worldwide vice president of medical affairs.

The Johnson & Johnson (NYSE:JNJ) subsidiary said Spaulding will lead its global clinical strategy starting June 1 from his home base in Paris.

Spaulding is director of the Cardiac Catheterization Laboratory at the City of Light’s Cochin Hospital and professor of medicine at René Descartes University, according to a press release. He was the principal investigator in the Typhoon trial comparing the sirolimus-eluting Cypher to bare-metal stents for for treating acute myocardial infarctions (heart attacks).

Christian Spaulding

Dr. Christian Spaulding

Spaulding also led the RES Elution trial comparing Cordis’s next-generation cobalt-chromium, reservoir-base, bioresorbable Conor stent with Boston Scientific Corp.’s (NYSE:BSX) Taxus Liberté paclitaxel-eluting stent. Cordis acquired Conor MedSystems for about $1.4 billion in 2006.

Cordis chief scientific officer Dr. Campbell Rogers told MassDevice last year that the company is placing a “big focus” on the Conor stent, which Cordis is now calling the Nevo.

“It’s a real departure, because it uses technology that … doesn’t coat the surface of the stent but rather fills reservoirs within the body of the stent with polymer and drug. It overcomes a large number of challenges with all of the current surface-coated drug-eluting stents, in terms of both acute success and also, we believe likely, in terms of long-term safety,” Rogers told us.

Filed Under: Business/Financial News, Drug-Eluting Stents, News Well Tagged With: Cordis Corp., Johnson and Johnson

More recent news

  • Real-world data backs Route 92 reperfusion system
  • LivsMed unveils new surgical robot with telesurgery capabilities
  • JenaValve enrolls first patient in TAVR for AR study
  • HistoSonics expands insurance coverage for histotripsy treatment
  • Johnson & Johnson MedTech gets updated FDA nod for Varipulse PFA

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy